相关实验视频

Updated: May 16, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

[对于Fanconi贫血的CRISPR-Cas9的进展]

Y M Gao¹, L X Chang¹, X F Zhu¹

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

|May 12, 2025

概括

克里斯普尔基因编辑对芬科尼贫血 (FA),一种骨髓衰竭疾病有前途. 虽然对基因修复有效,但诸如非目标效应和瘤发生等挑战需要进一步研究以获得安全和个性化的FA治疗方法.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
基因治疗基因治疗

背景情况:

芬科尼贫血 (FA) 是一种遗传性骨髓衰竭综合征.
FA的特点是基因组不稳定性和对DNA交叉链接剂的敏感性.

研究的目的:

审查关于CRISPR技术用于治疗Fanconi贫血的最新研究.
分析CRISPR-Cas9基因编辑在FA中的优缺点.

主要方法:

在FA中审查CRISPR-Cas9,单基编辑和主要编辑应用程序.
对FA基因编辑当前挑战和未来研究方向的分析.

主要成果:

在FA基因编辑中,CRISPR-Cas9和单基编辑已成功应用.
主编辑技术为FA基因编辑提供了新的可能性,尽管尚未启动.
挑战包括干细胞采集,瘤发生风险,染色体不稳定性和非目标效应.

结论:

克里斯普技术在治疗Fanconi贫血方面具有显著的潜力.
未来的研究应该专注于优化CRISPR系统,减少非目标效应和个性化.
解决伦理,监管和长期后续问题对于临床翻译至关重要.

更多相关视频

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution

Published on: February 26, 2019

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...